Skip to main content

Neurotrophic Keratitis News

FDA Approves Oxervate (cenegermin) for Neurotrophic Keratitis

August 22, 2018 – The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the...

Ask a question

To post your own question to our community, sign in or create an account.